Virology and Diseases Control

Therapeutics and Antiviral Agents

Embark on an enlightening journey into the realm of therapeutics and antiviral agents in this pivotal track. Explore the forefront of drug discovery, development, and clinical application, unveiling innovative strategies to combat viral infections and alleviate disease burden. Delve into the molecular mechanisms of viral replication and pathogenesis, uncovering vulnerabilities and targets for therapeutic intervention. Investigate the latest advancements in antiviral drug design, from small molecule inhibitors to biologics and gene-based therapies, revolutionizing treatment options for viral diseases.

Explore synergistic approaches such as combination therapy and immunomodulation, enhancing efficacy and reducing the risk of resistance. Join us as we navigate the complexities of drug development pipelines, clinical trials, and regulatory pathways, accelerating the translation of promising candidates into safe and effective therapies. Whether you're a pharmaceutical researcher, clinician, or healthcare provider, this track offers a comprehensive exploration of therapeutics and antiviral agents, paving the way for improved patient outcomes and global health security.

• Development of antiviral drugs

• Mechanisms of antiviral action

• Resistance to antiviral therapy

• Combination therapies and drug cocktails